Senior insider sale
EVP Research & Development at CYTOKINETICS INC — senior position signals high conviction
$3.38M
42K shares
What this filing means
MALIK FADY IBRAHAM plans to sell 42K shares of CYTOKINETICS INC valued at approximately $3.38M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001950047-26-006933
Officer· EVP Research & Development
Since Jul 2018
42K
Shares to sell
$3.38M
Approx. market value
24.50K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/7/2026
24.50KTotal acquired24.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/7/2026 | Exercise of Stock Options Cash | 24.50K | — |
| Total | 24.50K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
3.50K
Market value
$278.3K
6/23/2026
—Completed
Units to sell
3.50K
Market value
$237.9K
6/9/2026
—Completed
Units to sell
3.50K
Market value
$264.9K
5/19/2026
—Completed
Units to sell
3.50K
Market value
$270.8K
5/5/2026
—Completed
Units to sell
3.50K
Market value
$229.9K
4/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
24.50K
Market value
$2.10M
7/7/2026
Total
Units
42K
Value
$3.38M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/23/2026 | 3.50K | $278.3K | — | Completed |
6/9/2026 | 3.50K | $237.9K | — | Completed |
5/19/2026 | 3.50K | $264.9K | — | Completed |
5/5/2026 | 3.50K | $270.8K | — | Completed |
4/21/2026 | 3.50K | $229.9K | — | Completed |
| Planned — Approximate Date | ||||
7/7/2026 | 24.50K | $2.10M | NASDAQ | Planned |
| Total | 42K | $3.38M | ||